FIELD: medicine, radiation therapy.
SUBSTANCE: the present innovation refers to radiosensitizers that contain as an active component halogenated derivatives of borated porphyrines that contain a great number of carboranic cells which are selectively accumulated in neoplasms' tissues in the irradiated volume and could be applied in such type of cancer therapy that include but are not restricted with boron-neutron-capturing therapy and photodynamic therapy. The present innovation , also, deals with applying these radiosensitizers for visualization of the tumor and treating the cancer.
EFFECT: higher efficiency.
35 cl, 2 dwg, 8 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
CARBORANYLPORPHYRINE AND USE THEREOF | 2007 |
|
RU2477161C2 |
METHOD OF PRODUCING BORATED PORPHYRINS | 2013 |
|
RU2551539C2 |
METHOD FOR DETERMINING ABSORBED DOSE FROM THERMAL NEUTRONS IN BORON-NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS | 2019 |
|
RU2709682C1 |
METHOD FOR DELIVERY OF BORON-CONTAINING PREPARATIONS FOR BORON NEUTRON CAPTURE THERAPY | 2014 |
|
RU2589822C2 |
METHOD OF MEASURING ABSORBED DOSE IN BORON NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS | 2015 |
|
RU2606337C1 |
METHOD OF PRODUCING A COMPOSITION FOR BORON-NEUTRON CAPTURE THERAPY OF MALIGNANT TUMORS (VERSIONS) | 2019 |
|
RU2720458C1 |
METHOD FOR PRODUCING CHLORINES AND PHARMACEUTICAL APPLICATIONS THEREOF | 2009 |
|
RU2513483C2 |
THERAPEUTIC AGENTS AND USE THEREOF | 2012 |
|
RU2606773C2 |
METHOD FOR PLANNING NEUTRON CAPTURE THERAPY | 2001 |
|
RU2212260C2 |
CARBORANE DERIVATIVES OF 4,4-DIFLUORO-4-BORA-3α,4α-DIASE-s-INDACENE SHOWING ANTI-TUMOR ACTIVITY | 2022 |
|
RU2789401C1 |
Authors
Dates
2007-11-20—Published
2002-06-05—Filed